Patent details

Basic Information

Publication number:

EP1135381

PCT Application Number:

PCT/IB/1999/001754

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999492929

PCT Publication Number:

WO/2000/032589

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ELETRIPTAN HYDROBROMIDE MONOHYDRATE

French Title of Invention:

MONOHYDRATE DE BROMHYDRATE D'ELETRIPTAN

German Title of Invention:

ELITRIPTAN HYDROBROMID MONOHYDRAT

SPC Number:

Dates

Filing date:

01/11/1999

Grant date:

11/08/2004

EP Publication Date:

11/08/2004

PCT Publication Date:

08/06/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/09/2001

EP B1 Publication Date:

11/08/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/11/2008

Expiration date:

01/11/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/11/1999

 

 

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, New York 10017, United States (US)

Name:

Pfizer Limited

Address:

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

12/08/2004

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

OGILVIE Ronald, James

Address:

United Kingdom (GB)

2

Name:

DALLMAN Christopher, Ian

Address:

United Kingdom (GB)

Priority

Priority Number:

9825988

Priority Date:

27/11/1998

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 403/06;

Filing date	Document type	Number of pages